| Literature DB >> 6761061 |
Abstract
Effects of Trigynon, a triphase low-dose oral contraceptive, containing ethinylestradiol and l-norgestrel in various proportions, on testosterone binding globulin, transcortin, thyroxine, free testosterone, free cortisol and free thyroxine as well as on plasma lipids and glucose tolerance were studied in 12 normal women treated for 3-6 months. Trigynon appears to have dominant estrogenic effects as evidenced from the increase in transport proteins and the decrease in free testosterone concentration. Plasma lipids were not significantly influenced; glucose tolerance was slightly, but not significantly decreased.Entities:
Keywords: Age Factors; Biology; Carbohydrate Metabolic Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Dehydroepiandrosterone; Examinations And Diagnoses; Family Planning; Glucose Metabolism Effects--analysis; Glucose Tolerance Test; Laboratory Examinations And Diagnoses; Laboratory Procedures; Lipid Metabolic Effects--analysis; Lipids; Metabolic Effects; Oral Contraceptives; Oral Contraceptives, Low-dose; Physiology; Reproductive Control Agents; Steroid Metabolic Effects; Testosterone
Mesh：
Substances：
Year: 1982 PMID： 6761061 DOI： 10.1016/0010-7824(82)90149-4
Source DB: PubMed Journal: Contraception ISSN： 0010-7824 Impact factor: 3.375